产品
编 号：F401410
分子式：C17H29ClN2O3
分子量：344.88
分子式：C17H29ClN2O3
分子量：344.88
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
5mg
询价
询价
10mg
询价
询价
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价
结构图
CAS No: 5987-82-6
产品详情
生物活性：
Oxybuprocaine hydrochloride (Benoxinate hydrochloride) reversibly blocks sodium channels and prevents propagation of painful nerve impulses in the cornea, conjunctiva, and sclera. Oxybuprocaine hydrochloride is used especially in ophthalmology and otolaryngology.
体内研究：
Oxybuprocaine hydrochloride (Benoxinate hydrochloride; 27.6, 51.7, 103.5, 413.9 μg; s.c.) provides a dose-dependent block to pinpricks in rats. Oxybuprocaine hydrochloride (27.6 μg) produces 100% of sensory/nociceptive block. Animal Model:Male Sprague-Dawley rats (203-253 g)
Dosage:27.6, 51.7, 103.5, 413.9 μg
Administration:SC
Result:Provided a dose-dependent block to pinpricks.
Oxybuprocaine hydrochloride (Benoxinate hydrochloride) reversibly blocks sodium channels and prevents propagation of painful nerve impulses in the cornea, conjunctiva, and sclera. Oxybuprocaine hydrochloride is used especially in ophthalmology and otolaryngology.
体内研究：
Oxybuprocaine hydrochloride (Benoxinate hydrochloride; 27.6, 51.7, 103.5, 413.9 μg; s.c.) provides a dose-dependent block to pinpricks in rats. Oxybuprocaine hydrochloride (27.6 μg) produces 100% of sensory/nociceptive block. Animal Model:Male Sprague-Dawley rats (203-253 g)
Dosage:27.6, 51.7, 103.5, 413.9 μg
Administration:SC
Result:Provided a dose-dependent block to pinpricks.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备